No Data
Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024
Earnings Week Ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and More
Åsa Manelius Named Managing Director of Novavax AB Site
Here Is What to Know Beyond Why Novavax, Inc. (NVAX) Is a Trending Stock
USDA Says H5N1 Bird Flu Detected In Swine For The First Time In U.S. In Oregon Backyard Farm; There Is No Concern About Safety Of The Nation's Pork Supply As A Result Of This Finding On HPAI Detections In Oregon Backyard Farm
USDA To Begin Bulk Milk Testing For Bird Flu Nationwide Following Pressure From Industry And Veterinary Groups; New Effort Aims To Curb Rapid Spread Among Dairy Herds
No Data
No Data
Stock Winner : No
Dafydd Green : That won’t happen. The recent slump is to do with one FDA pause on a trial - and is very likely to restart again soon. The restart will cause a price surge and draw attention again to its influenza portfolio - which is strong. Bears, I don’t think there’s much left to squeeze here